Walleye Trading’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$61M Buy
849,800
+73,400
+9% +$5.65M 0.1% 205
2025
Q4
$61.6M Buy
776,400
+171,200
+28% +$13.5M 0.09% 230
2025
Q3
$45.6M Sell
605,200
-165,800
-22% -$11.4M 0.07% 284
2025
Q2
$53.2M Buy
771,000
+231,100
+43% +$15.2M 0.1% 209
2025
Q1
$36.6M Buy
539,900
+176,200
+48% +$10.5M 0.08% 246
2024
Q4
$16.3M Buy
363,700
+90,800
+33% +$5.09M 0.03% 557
2024
Q3
$17.2M Sell
272,900
-216,600
-44% -$12.6M 0.04% 521
2024
Q2
$28.9M Buy
489,500
+375,100
+328% +$23.5M 0.07% 300
2024
Q1
$9.12M Sell
114,400
-301,100
-72% -$23M 0.02% 771
2023
Q4
$32.8M Sell
415,500
-332,500
-44% -$23.7M 0.07% 274
2023
Q3
$52.2M Buy
748,000
+223,400
+43% +$15.8M 0.14% 117
2023
Q2
$36.3M Buy
524,600
+330,100
+170% +$23.5M 0.11% 164
2023
Q1
$14.5M Sell
194,500
-250,700
-56% -$21M 0.03% 484
2022
Q4
$41.5M Buy
445,200
+164,400
+59% +$15.9M 0.12% 165
2022
Q3
$26.8M Buy
280,800
+61,900
+28% +$6.13M 0.08% 233
2022
Q2
$20.3M Sell
218,900
-98,100
-31% -$9.57M 0.07% 317
2022
Q1
$32.1M Buy
317,000
+59,300
+23% +$6.23M 0.1% 204
2021
Q4
$26.6M Sell
257,700
-91,300
-26% -$8.44M 0.09% 225
2021
Q3
$29.6M Buy
349,000
+2,700
+0.8% +$226K 0.11% 179
2021
Q2
$28.9M Buy
346,300
+94,300
+37% +$7.72M 0.11% 146
2021
Q1
$19M Buy
252,000
+26,000
+12% +$1.89M 0.08% 165
2020
Q4
$15.4M Sell
226,000
-77,500
-26% -$5.04M 0.07% 239
2020
Q3
$17.7M Buy
303,500
+121,400
+67% +$7.55M 0.09% 152
2020
Q2
$11.8M Buy
182,100
+61,200
+51% +$3.85M 0.08% 226
2020
Q1
$7.17M Sell
120,900
-370,906
-75% -$24.8M 0.06% 272
2019
Q4
$36.5M Buy
491,806
+107,800
+28% +$7.57M 0.25% 51
2019
Q3
$24.2M Buy
384,006
+116,296
+43% +$6.89M 0.21% 58
2019
Q2
$14.6M Buy
267,710
+65,952
+33% +$3.55M 0.13% 123
2019
Q1
$10.9M Sell
201,758
-141,269
-41% -$8.72M 0.08% 226
2018
Q4
$22.5M Buy
343,027
+172,427
+101% +$12.9M 0.17% 83
2018
Q3
$13.4M Buy
170,600
+54,200
+47% +$3.87M 0.07% 231
2018
Q2
$7.49M Sell
116,400
-157,800
-58% -$10.4M 0.04% 406
2018
Q1
$17.1M Buy
274,200
+184,200
+205% +$13.2M 0.1% 131
2017
Q4
$6.53K Sell
90,000
-72,600
-45% -$5.28M 0.03% 533
2017
Q3
$13.2K Buy
162,600
+100,100
+160% +$7.92M 0.07% 219
2017
Q2
$5.03K Sell
62,500
-195,100
-76% -$15.4M 0.03% 574
2017
Q1
$20.2K Buy
257,600
+224,900
+688% +$18M 0.14% 88
2016
Q4
$2.58M Sell
32,700
-56,600
-63% -$4.58M 0.02% 802
2016
Q3
$7.95M Buy
89,300
+41,100
+85% +$3.88M 0.05% 253
2016
Q2
$4.62M Sell
48,200
-116,100
-71% -$11.6M 0.03% 481
2016
Q1
$17M Buy
164,300
+133,800
+439% +$13M 0.15% 102
2015
Q4
$2.98M Buy
30,500
+8,600
+39% +$842K 0.03% 564
2015
Q3
$2.11M Sell
21,900
-3,700
-14% -$389K 0.02% 636
2015
Q2
$2.68M Buy
25,600
+8,400
+49% +$858K 0.03% 560
2015
Q1
$1.77M Sell
17,200
-800
-4% -$80.9K 0.02% 700
2014
Q4
$1.74M Sell
18,000
-7,600
-30% -$670K 0.02% 750
2014
Q3
$2.04M Buy
25,600
+10,500
+70% +$828K 0.02% 441
2014
Q2
$1.14K Sell
15,100
-21,000
-58% -$1.59M 0.02% 727
2014
Q1
$2.7K Buy
36,100
+15,800
+78% +$1.12M 0.04% 325
2013
Q4
$1.45M Buy
20,300
+9,300
+85% +$598K 0.01% 844
2013
Q3
$625K Sell
11,000
-38,600
-78% -$2.3M 0.01% 1096
2013
Q2
$2.84M Buy
+49,600
New +$2.87M 0.03% 455

Other funds holding CVS

Walleye Trading's CVS Position: Q1 2026 in Review

Walleye Trading increased its CVS Health (CVS) stake by 45% in Q1 2026, buying an estimated $10.3M and bringing the position to 427,542 shares worth $30.7M. The position accounts for 0.05% of the portfolio, ranked #361.

Walleye Trading first reported a position in CVS in Q3 2013 and has held it in 39 quarters since. The position peaked at $37.3M in Q4 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Walleye Trading held 427,542 shares of CVS Health worth $30.7M as of Q1 2026.
  • Walleye Trading bought 133,578 CVS Health shares in Q1 2026, an estimated $10.3M.
  • CVS Health made up 0.05% of Walleye Trading's portfolio in Q1 2026, its #361 holding.
  • Walleye Trading first reported a position in CVS Health in Q3 2013 and has held it in 39 quarters since.
  • Walleye Trading's CVS Health position peaked at $37.3M in Q4 2023.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.